Obesity, defined as a body mass index (BMI) of 30 or more, is a global health issue that poses significant challenges to healthcare professionals. It is associated with numerous comorbidities, including cardiovascular disease, type 2 diabetes, and certain types of cancer. Effective management strategies are crucial to mitigate these risks and improve patient outcomes.
Managing obesity requires a multidisciplinary approach that includes dietitians, psychologists, exercise physiologists, and physicians. Diet and exercise interventions are first-line treatments, but these require significant patient motivation and long-term adherence to be effective. Psychological support can help patients address barriers to lifestyle change and improve adherence.
When lifestyle interventions are insufficient, pharmacological treatments may be considered. Several medications, including orlistat, liraglutide, and bupropion-naltrexone, have been shown to promote weight loss when combined with lifestyle modifications. However, these medications have side effects and contraindications that must be carefully considered.
Bariatric surgery is the most effective treatment for severe obesity (BMI > 40) or moderate obesity (BMI 35-40) with comorbidities. Procedures such as sleeve gastrectomy and gastric bypass can lead to significant and sustained weight loss, but they also carry risks and require lifelong medical follow-up.
Emerging treatments for obesity include novel pharmaceutical agents, endoscopic procedures, and neuromodulation techniques. More research is needed to determine their efficacy and safety. In addition, efforts are underway to better understand the genetic and environmental factors contributing to obesity, which may lead to more personalized treatment strategies.
Obesity management is complex and requires a comprehensive, multidisciplinary approach. Lifestyle interventions remain the cornerstone of treatment, but pharmacological therapies and bariatric surgery play important roles in certain patients. Future research will undoubtedly uncover new strategies for managing this pervasive health issue.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation